Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA Filing
SeaStar Medical Reaches Interim Enrollment Target for NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury
Seeking Alpha / 1 hour from now 1 Views
Indication Has Been Granted FDA Breakthrough Device Designation for Potential PMA Filing
Comments